En bloc excision of a large hydatid cyst originating from the posterior wall of the left ventricle.

Multimed Man Cardiothorac SurgOct 16, 2026 (epub)
Case ReportCardiothoracic Surgery

Koray Ak, Çağrı Gürpınar, Fatih Öztürk et al.

✦ AI-curated · Sources linked

Case in brief

A male patient was found incidentally to have a hydatid cyst arising from the posterior wall of the left ventricle. The cyst was completely removed en bloc through a left ventriculotomy. The report presents the operative approach and technical considerations for resection.

What made this case unusual

The cyst originated from the posterior left ventricular wall, and the report focuses on its complete en bloc excision through a left ventriculotomy.

Diagnostic / clinical pearl

An incidentally detected cardiac hydatid cyst may warrant surgical resection because rupture or cardiac chamber compression can cause life-threatening complications.

Source

PubMed · PMID 42885646

Published in Multimed Man Cardiothorac Surg. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiothoracic Surgery

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.